Allovir Stock Analysis

Allovir Stock Analysis Notes

About 49.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.74. Some equities with similar Price to Book (P/B) outperform the market in the long run. Allovir recorded a loss per share of 1.23. The entity had not issued any dividends in recent years. The firm had 1:10 split on the April 2, 2013. Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell therapies to prevent and treat devastating viral-associated diseases. Allovir, Inc. was founded in 2013 and is based in Waltham, Massachusetts. Allovir operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 107 people. For more info on Allovir please contact Diana MD at 617 433 2605 or go to https://www.allovir.com.

Allovir Investment Alerts

Allovir Upcoming and Recent Events

Allovir Largest EPS Surprises

View All Earnings Estimates

Allovir Stock Institutional Investors

Note, although Allovir's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Allovir Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 89.19 M.

Allovir Profitablity

Management Efficiency

Allovir has return on total asset (ROA) of (0.3653) % which means that it has lost $0.3653 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8033) %, meaning that it created substantial loss on money invested by shareholders. Allovir's management efficiency ratios could be used to measure how well Allovir manages its routine affairs as well as how well it operates its assets and liabilities. As of 10/19/2024, Return On Tangible Assets is likely to grow to -0.95. In addition to that, Return On Capital Employed is likely to drop to -1.17. At this time, Allovir's Total Assets are relatively stable compared to the past year. As of 10/19/2024, Other Current Assets is likely to grow to about 4.3 M, while Non Current Assets Total are likely to drop slightly above 3 M.

Technical Drivers

As of the 19th of October, Allovir shows the Mean Deviation of 2.23, risk adjusted performance of 0.0236, and Downside Deviation of 3.13. Allovir technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Allovir downside deviation, treynor ratio, as well as the relationship between the Treynor Ratio and expected short fall to decide if Allovir is priced correctly, providing market reflects its regular price of 0.77 per share. As Allovir is a penny stock we also strongly suggest to validate its total risk alpha numbers.

Allovir Price Movement Analysis

Allovir Insider Trading Activities

Allovir Outstanding Bonds

Allovir Predictive Daily Indicators

Allovir Forecast Models

Allovir's time-series forecasting models are one of many Allovir's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Allovir's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Allovir prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Allovir shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Allovir. By using and applying Allovir Stock analysis, traders can create a robust methodology for identifying Allovir entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Allovir analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Allovir analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Allovir stock analysis indicators help investors evaluate how Allovir stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Allovir shares will generate the highest return on investment. By understating and applying Allovir stock analysis, traders can identify Allovir position entry and exit signals to maximize returns.

When running Allovir's price analysis, check to measure Allovir's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Allovir is operating at the current time. Most of Allovir's value examination focuses on studying past and present price action to predict the probability of Allovir's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Allovir's price. Additionally, you may evaluate how the addition of Allovir to your portfolios can decrease your overall portfolio volatility.